Prev: Review for the generalist: The antinuclear antibody test in children - When to use it and what to do with a positive titerNext: Anti-DFS70 Antibodies for Differentiating Systemic Autoimmune Rheumatic Disease in Patients with Positive ANA Tests: A Systematic Review and Meta-Analysis
Record 056 · Research · 2012
Prevalence and sociodemographic correlates of antinuclear antibodies in the United States
Arthritis & Rheumatism · requested inclusion
“National survey analysis found ANA positivity in 13.8% of the US population aged 12 and older in 1999–2004, with variation by age and sex.”
National survey analysis found ANA positivity in 13.8% of the US population aged 12 and older in 1999–2004, with variation by age and sex. Limits noted in the record: Cross-sectional historical survey; estimates depend on assay and population. A positive ANA is not a diagnosis. Claims in this record are not verified.
A positive ANA is not a diagnosis. Claims in this record are not verified.
source
- prevalence
- healthy-people
- demographics
Research
Also in this file
View all in file
Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases11.41.E · Arthritis & Rheumatism
Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify?22.34.E · Archives of Rheumatology
Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease23.35.E · BMC Rheumatology
High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease08.36.E · Lupus